These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21503727)

  • 1. Evolutionary game theoretic strategy for optimal drug delivery to influence selection pressure in treatment of HIV-1.
    Wu Y; Zhang M; Wu J; Zhao X; Xia L
    J Math Biol; 2012 Feb; 64(3):495-512. PubMed ID: 21503727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple HIV-1 infection of cells and the evolutionary dynamics of cytotoxic T lymphocyte escape mutants.
    Wodarz D; Levy DN
    Evolution; 2009 Sep; 63(9):2326-39. PubMed ID: 19486149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial.
    Ide F; Nakamura T; Tomizawa M; Kawana-Tachikawa A; Odawara T; Hosoya N; Iwamoto A
    J Med Virol; 2006 Jun; 78(6):711-8. PubMed ID: 16628588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells.
    Macatonia SE; Patterson S; Knight SC
    Immunology; 1991 Nov; 74(3):399-406. PubMed ID: 1769689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
    Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
    Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
    Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1(+) patients.
    Papasavvas E; Foulkes A; Yin X; Joseph J; Ross B; Azzoni L; Kostman JR; Mounzer K; Shull J; Montaner LJ
    Immunology; 2015 Jul; 145(3):380-90. PubMed ID: 25684333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
    Price DA; O'callaghan CA; Whelan JA; Easterbrook PJ; Phillips RE
    Clin Sci (Lond); 1999 Dec; 97(6):707-18. PubMed ID: 10585898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells as targets for cytotoxic T lymphocytes.
    Knight SC; Askonas BA; Macatonia SE
    Adv Exp Med Biol; 1997; 417():389-94. PubMed ID: 9286391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.
    Smith KN; Mailliard RB; Piazza PA; Fischer W; Korber BT; Fecek RJ; Ratner D; Gupta P; Mullins JI; Rinaldo CR
    mBio; 2016 May; 7(3):. PubMed ID: 27247230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.
    Mollet L; Li TS; Samri A; Tournay C; Tubiana R; Calvez V; Debré P; Katlama C; Autran B
    J Immunol; 2000 Aug; 165(3):1692-704. PubMed ID: 10903781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment.
    Wodarz D; Nowak MA
    Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1059-70. PubMed ID: 11186307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells reveal a broad range of MHC class I epitopes for HIV-1 in persons with suppressed viral load on antiretroviral therapy.
    Huang XL; Fan Z; Borowski L; Mailliard RB; Rolland M; Mullins JI; Day RD; Rinaldo CR
    PLoS One; 2010 Sep; 5(9):e12936. PubMed ID: 20886040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fuzzy modeling and control of HIV infection.
    Zarei H; Kamyad AV; Heydari AA
    Comput Math Methods Med; 2012; 2012():893474. PubMed ID: 22536298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection.
    Pillay T; Zhang HT; Drijfhout JW; Robinson N; Brown H; Khan M; Moodley J; Adhikari M; Pfafferott K; Feeney ME; St John A; Holmes EC; Coovadia HM; Klenerman P; Goulder PJ; Phillips RE
    J Virol; 2005 Sep; 79(18):12100-5. PubMed ID: 16140787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
    J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1-infected T-cells dynamics and prognosis: An evolutionary game model.
    Khazaei B; Sartakhti JS; Manshaei MH; Zhu Q; Sadeghi M; Mousavi SR
    Comput Methods Programs Biomed; 2017 Dec; 152():1-14. PubMed ID: 29054249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cultured blood dendritic cells retain HIV-1 antigen-presenting capacity for memory CTL during progressive HIV-1 infection.
    Fan Z; Huang XL; Zheng L; Wilson C; Borowski L; Liebmann J; Gupta P; Margolick J; Rinaldo C
    J Immunol; 1997 Nov; 159(10):4973-82. PubMed ID: 9366424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral dynamics model with CTL immune response incorporating antiretroviral therapy.
    Wang Y; Zhou Y; Brauer F; Heffernan JM
    J Math Biol; 2013 Oct; 67(4):901-34. PubMed ID: 22930342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.